-

FUJIFILM Sonosite Promotes Dennis Giacomino to Chief Commercial Officer

BOTHELL, Wash.--(BUSINESS WIRE)--FUJIFILM Sonosite, Inc., the world leader in point-of-care ultrasound (POCUS) solutions, is pleased to announce that Dennis Giacomino has been promoted to the newly created role of Chief Commercial Officer, effective April 1, 2025, continuing to report to FUJIFILM Sonosite’s President and Chief Executive Officer, Richard Fabian.

Giacomino is a FUJIFILM Sonosite veteran, serving in progressively senior roles in the sales and customer experience function since joining the company in 2009. In his new role, he will assume responsibility for the company’s global commercial business leading sales, sales enablement, and market development of FUJIFILM Sonosite products globally.

"As FUJIFILM Sonosite continues its leadership in the POCUS solutions category, we developed the role of Chief Commercial Officer to ensure long-term growth and success as we continue our global expansion efforts to ensure clinicians around the world have access to FUJIFILM Sonosite ultrasound systems,” said Fabian. "Across his various roles at Fujifilm, Dennis has established a track record of entering new markets, scaling operations, and delivering strong growth performance. We are pleased to have him at the helm of our commercial and customer experience team, consistently delivering the highest level of focus on our customers' success and their ability to provide the best care for their patients.”

“FUJIFILM Sonosite’s commitment to being the most trusted, reliable, and easy to use point-of-care ultrasound partner, coupled with our ambitious long-term growth plans makes the chief commercial officer role a fantastic opportunity,” said Giacomino. “I am thrilled to continue to lead our amazing team that is driven by a passion to help our clinicians solve their problems and execute on the company’s vision to improve patient outcomes and quality of care.”

Dennis is based at FUJIFILM Sonosite’s headquarters in Bothell, Washington.

About FUJIFILM
FUJIFILM Sonosite, Inc. is the innovator and world leader in bedside and point-of-care ultrasound, and an industry leader in ultra-high frequency micro-ultrasound technology. Headquartered near Seattle, the company is represented by a global distribution network in over 100 countries. Sonosite’s portable, compact systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high-performance ultrasound to the point of patient care. For more information, please visit www.sonosite.com.

FUJIFILM Holdings Corporation, headquartered in Tokyo, leverages its depth of knowledge and proprietary core technologies to deliver innovative products and services across the globe through the four key business segments of healthcare, electronics, business innovation, and imaging with over 70,000 employees. Guided and united by our Group Purpose of “giving our world more smiles,” we address social challenges and create a positive impact on society through our products, services, and business operations. Under its medium-term management plan, VISION2030, which ends in FY2030, we aspire to continue our evolution into a company that creates value and smiles for various stakeholders as a collection of global leading businesses and achieve a global revenue of 4 trillion yen. For more information, please visit: www.fujifilmholdings.com.

Contacts

Marissa Confredo
914-343-4761
Marissa.confredo@fujifilm.com

FUJIFILM Sonosite, Inc.


Release Versions

Contacts

Marissa Confredo
914-343-4761
Marissa.confredo@fujifilm.com

Social Media Profiles
More News From FUJIFILM Sonosite, Inc.

Ardent Health and Fujifilm Partner to Deliver Synapse Enterprise Imaging Across Radiology and Cardiology Throughout All Facilities

BRENTWOOD, Tenn. & LEXINGTON, Mass.--(BUSINESS WIRE)--Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., has partnered with FUJIFILM Healthcare Americas Corporation to implement its Synapse® enterprise imaging solutions across Ardent's acute care hospital footprint across six states. Fujifilm’s Synapse Enterprise Imaging solutions will provide Ardent clinicians with a single, holistic view of patient imaging data across various d...

Fujifilm’s ELUXEO 8000® Endoscopic Imaging System in Combination with 840TP Gastroscope Wins 2026 MedTech Breakthrough Award

LEXINGTON, Ma.--(BUSINESS WIRE)--FUJIFILM Healthcare Americas Corporation, a leading provider of endoscopic imaging and endosurgical solutions, announced that its ELUXEO® 8000 Endoscopic Imaging System coupled with its EG-840TP ultra slim therapeutic gastroscope has been selected as the winner of the “Best New Endoscopy Technology Solution” award in the 10th annual MedTech Breakthrough Awards program. MedTech Breakthrough is an independent market intelligence organization that recognizes the to...

Fujifilm Develops Novel Screening Platform to Identify High-Affinity Cyclic Peptides for Challenging Membrane Protein Targets  

TOKYO--(BUSINESS WIRE)--FUJIFILM Corporation announced today that it has developed an innovative screening methodology for cyclic peptides exhibiting high affinity toward membrane proteins1. This new technology enables Fujifilm to offer cyclic peptide discovery services targeting challenging membrane proteins, including multi-pass transmembrane proteins2, which represent complex drug targets. The results of this study are scheduled to be presented at TIDES USA, an exhibition from May 11 to 14,...
Back to Newsroom